"PUR's technologies will bring new solutions for pain elimination and osteoarthritis." IRVINE, CA / ACCESSWIRE / April 25, 2022 / ORHub, Inc. (OTC PINK:ORHB) announced today it has purchased 100% of the equity...
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed announced today that it closed an oversubscribed $30M Series B funding round, led by B Capital Group, a global, multi-stage investment firm. Existing investors, U.S. Venture Partners,...
CHICAGO, April 12, 2022 /PRNewswire/ -- According to the new market research report "Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections),...
NanoHive Medical, LLC announced today that the company has closed on an oversubscribed Growth Financing round to support its product expansion and commercialization efforts. Outcome Capital served as the strategic...
The recent report on 'North America Orthopedic Devices Market' outlines the growth catalyzing variables as well as the determinants that are likely to obstruct industry development over the projected timeframe...
The acquisition of TheraCell, Inc. will expand Isto's portfolio of best-in-class procedure specific allografts to help patients heal faster. LOS ANGELES, April 5, 2022 /PRNewswire/ -- TheraCell Inc., a leading allograft solution company, today announced...
Biomedical Bonding AB has, together with consortium partners KTH Royal Institute of Technology, RISE Research Institutes of Sweden and The Karolinska Institute/Stockholm South General Hospital secured 3 MSEK in funding...
DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has exercised its call...
Proceeds Will Support Clinical Advancement of SB-01 For Injection for Treatment of Degenerative Disc Disease NEW YORK, March 28, 2022 /PRNewswire/ -- Spine BioPharma, Inc., a biopharmaceutical company committed to developing non-opiate, non-surgical therapies for the...
SAN FRANCISCO, March 24, 2022 /PRNewswire/ -- Osso VR, a validated virtual reality (VR) surgical training and assessment platform, today announced that it has secured $66 million in Series C funding led by Oak HC/FT....